8-K
filed November 2, 2023, 7:59 PM ET
ticker ENVB
CIK 0000890821
other material
confidence high
sentiment neutral
materiality 0.65
Enveric stockholders approve amended 2020 LTIP and share issuance to Lincoln Park Capital
Enveric Biosciences, Inc.
- Stockholders approved amendment to 2020 LTIP, increasing authorized shares by 38,259 to 350,000.
- Amendments remove evergreen auto-increase provision and add one-year minimum vesting.
- Issuance of common stock to Lincoln Park Capital Fund approved under Nasdaq Listing Rules 5635(a), (b), (d).
- All five director nominees elected; say-on-pay and ratification of Marcum LLP as auditor passed.
- Annual meeting turnout: 1,074,661 shares (49.3% of outstanding) constituted quorum.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Enveric Biosciences, Inc. shareholders approved Non-binding advisory vote to approve the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. at the 2023-11-02 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-11-02
Exact text from the filing
Non-binding advisory vote to approve the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Enveric Biosciences, Inc. shareholders approved Approval of proposed amendments to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan, as amended. at the 2023-11-02 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-11-02
Exact text from the filing
Approval of proposed amendments to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan, as amended.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Enveric Biosciences, Inc. shareholders approved Ratification of the appointment of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. at the 2023-11-02 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-11-02
Exact text from the filing
Ratification of the appointment of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Enveric Biosciences, Inc. shareholders approved Approval of the issuance of shares of common stock to Lincoln Park Capital Fund, LLC pursuant to Nasdaq Listing Rules 5635(a), 5635(b) and 5635(d). at the 2023-11-02 meeting.
- Outcome
- passed
- Meeting
- 2023-11-02
Exact text from the filing
Approval of the issuance of shares of common stock to Lincoln Park Capital Fund, LLC pursuant to Nasdaq Listing Rules 5635(a), 5635(b) and 5635(d).
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Enveric Biosciences, Inc. shareholders approved Election of five directors, to serve until the Company's 2024 annual meeting of stockholders or until their successors are duly elected and qualified. at the 2023-11-02 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-11-02
Exact text from the filing
On November 2, 2023, the Company held its 2023 Annual Meeting.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.